Prognostic Value of Risk Score and Urinary Markers in Idiopathic Membranous Nephropathy

被引:44
作者
van den Brand, Jan A. J. G. [1 ]
Hofstra, Julia M. [1 ]
Wetzels, Jack F. M. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6500 HB Nijmegen, Netherlands
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 7卷 / 08期
关键词
ACETYL-BETA-GLUCOSAMINIDASE; GLOMERULAR-FILTRATION-RATE; EXCRETION; GLOMERULONEPHRITIS; BETA-2-MICROGLOBULIN; VALIDATION; PROTEINS;
D O I
10.2215/CJN.00670112
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives Accurate prediction of prognosis may improve management of patients with idiopathic membranous nephropathy. This study compared the Toronto Risk Score and urinary low-molecular weight proteins. Design, setting, participants, & measurements One hundred four patients with biopsy-proven idiopathic membranous nephropathy who presented between 1995 and 2008 with a well-preserved kidney function and nephrotic range proteinuria were included. Urinary beta 2-microglobulin and alpha 1-microglobulin measurements were obtained by timed standardized measurements, and the Toronto Risk Score was calculated using data obtained from medical records. The endpoint was progression, which was defined as an increase in serum creatinine>50% or >25% with a concentration>135 mu mol/L. Results Forty-nine patients showed progression. The area under the receiver-operating characteristics curve was 0.78 (95% confidence interval=0.69-0.88) for the risk score versus 0.80 (0.71-0.89) and 0.79 (0.71-0.88) for urinary beta 2- and alpha 1-microglobulin, respectively. Differences were not significant. Persistent proteinuria did not add accuracy to the Toronto Risk Score. Conversely, its accuracy was not reduced when data from the first 6 months of follow-up were used. Furthermore, a score based on GFR estimated with the six-variable Modification of Diet in Renal Disease equation, calculated in the first 6 months of follow-up, gave an area under the receiver-operating characteristics curve of 0.83 (0.74-0.92), which was not statistically different from other markers. Conclusions The prognostic accuracies of the Toronto Risk Score and urinary low-molecular weight proteins were not significantly different. The risk score can be calculated within 6 months of diagnosis, and a simplified risk score using estimated GFR Modification of Diet in Renal Disease may be sufficient. Clin J Ant Soc Nephrol 7: 1242-1248, 2012. doi: 10.2215/CJN.00670112
引用
收藏
页码:1242 / 1248
页数:7
相关论文
共 21 条
[1]   Urinary N-acetyl-β-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis [J].
Bazzi, C ;
Petrini, C ;
Rizza, V ;
Arrigo, G ;
Napodano, P ;
Paparella, M ;
D'Amico, G .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (11) :1890-1896
[2]   Urinary excretion of β2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy:: A validation study [J].
Branten, AJW ;
du Buf-Vereijken, PW ;
Klasen, IS ;
Bosch, FH ;
Feith, GW ;
Hollander, DA ;
Wetzels, JF .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (01) :169-174
[3]   Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications [J].
Cattran, DC ;
Pei, Y ;
Greenwood, CMT ;
Ponticelli, C ;
Passerini, P ;
Honkanen, E .
KIDNEY INTERNATIONAL, 1997, 51 (03) :901-907
[4]   Idiopathic membranous nephropathy: Outline and rationale of a treatment strategy [J].
du Buf-Vereijken, PWG ;
Branten, AJW ;
Wetzels, JFM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (06) :1012-1029
[5]   Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy [J].
Hofstra, Julia M. ;
Deegens, Jeroen K. J. ;
Steenbergen, Eric J. ;
Wetzels, Jack F. M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (10) :3160-3165
[6]   Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy [J].
Hofstra, Julia M. ;
Deegens, Jeroen K. J. ;
Willems, Hans L. ;
Wetzels, Jack F. M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (08) :2546-2551
[7]   Management of patients with membranous nephropathy [J].
Hofstra, Julia M. ;
Wetzels, Jack F. M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (01) :6-9
[8]   Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy [J].
Hofstra, Julia M. ;
Beck, Laurence H., Jr. ;
Beck, David M. ;
Wetzels, Jack F. ;
Salant, David J. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (06) :1286-1291
[9]   Estimated glomerular filtration rate in the nephrotic syndrome [J].
Hofstra, Julia M. ;
Willems, Johannes L. ;
Wetzels, Jack F. M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (02) :550-556
[10]   Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial [J].
Hofstra, Julia M. ;
Branten, Amanda J. W. ;
Wirtz, Joris J. J. M. ;
Noordzij, Ton C. ;
du Buf-Vereijken, Peggy W. G. ;
Wetzels, Jack F. M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (01) :129-136